Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
about
Overview of the biology of type I interferonsDefects in Germinal Center Selection in SLEIntracellular nucleic acid sensors and autoimmunityProliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesInterferon-alpha: a therapeutic target in systemic lupus erythematosusInterferon alpha in systemic lupus erythematosusActivation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Requirements for innate immune pathways in environmentally induced autoimmunity.Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosusB Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 miceA unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.TLR7 influences germinal center selection in murine SLE.The role of cytokine in the lupus nephritis.Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFκB and ERK.Cytokine disturbances in systemic lupus erythematosus.Janus-like effects of type I interferon in autoimmune diseases.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisThe Yaa locus and IFN-α fine-tune germinal center B cell selection in murine systemic lupus erythematosusAnti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed miceExpression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in MexicoTaming lupus-a new understanding of pathogenesis is leading to clinical advances.Differential regulation of cell death programs in males and females by Poly (ADP-Ribose) Polymerase-1 and 17β estradiolIFNα Inducible Models of Murine SLE.The effect of BAFF inhibition on autoreactive B cell selection in murine SLE.Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritisRecent advances in cytokines in cutaneous and systemic lupus erythematosus.Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity.The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.Future prospects in biologic therapy for systemic lupus erythematosus.New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic.Plasma cells in systemic lupus erythematosus: the long and short of it all.Mouse models of lupus: what they tell us and what they don't.
P2860
Q21195364-077F60BA-571D-4E4A-BD18-F250FAD1A004Q26796041-2B31A10C-5EBC-40F1-92B3-4A38681CD1ACQ26997316-A8A51A32-3E00-4265-A520-0C6BC50A91F9Q33733803-EFC882B1-F628-4DF4-9919-02BE8A9667C5Q33744320-56DA415A-C5C3-4177-8AA8-A054E8974A3AQ33961179-0BA2358A-B598-4D9D-9632-530272F38BE3Q34240254-C8CBFDFA-1FEF-41C0-B736-BDA9FD04DBEEQ34655526-3A427AA2-73C2-4DED-B3AD-96E5BB17D71AQ34672353-7BFA4167-C14C-4F83-86A9-93AD52406917Q34781487-9FDEC92D-4604-428F-8DC5-6EBF859666AFQ35118781-C05A2617-E530-4B9E-AFB0-F1216BAB2265Q35174510-99F349B4-5A8E-4E61-BB54-85F4B4912DC5Q35202579-747C7AF4-D878-4D8B-A77E-D61FF4BE512EQ35418333-67C8FB39-4A95-4A28-A546-A53686480483Q35536652-7881CADC-22B2-4A0F-BD1E-ED6E849F4A6DQ35617573-514A2986-3181-4E33-95AA-447240D7AFBCQ36059960-3F35C29C-C91A-4C57-99A1-B8C7A19F28DDQ36139902-729CE853-D91E-45A7-9423-9935ED38E77EQ36339344-8F9A0D10-6427-442D-8034-58FC0FC33023Q36490737-0A0030FA-6313-479F-A04A-F3BA17CD7C27Q36527339-9481E317-692A-4526-8727-BE98CF9DD525Q36712941-BCB554F3-BFF5-4ECE-8542-97FE9185E7FEQ37148205-DA64EBAF-57B8-4DFC-85DD-694104AFAA3AQ37210594-5616F5B3-221A-4E73-B363-5C91A9B8F91FQ37217047-E2EA17E7-9FCF-4C8E-802B-69A95AEF116AQ37221965-DA7EAF2B-7B90-4786-B3AD-C364574448A1Q37902251-7E4817F3-E5D2-4E83-9628-D32D09240869Q37950925-189C76CA-8846-4C83-A0B2-0EC21CB71FCAQ38085723-E2768329-34C1-40AE-9978-EB826CF1EA09Q38135706-F9BCFF4D-7F3D-4145-BC94-DF4FCF065E04Q38148585-9AE22F52-B227-4C88-8111-EF1B91637C81Q45938061-60CD307A-4715-4995-A4DA-35D020CAE074Q50224231-2E7C7BDB-C794-4E3B-B548-E6F9E7817518
P2860
Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@ast
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@en
type
label
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@ast
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@en
prefLabel
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@ast
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@en
P2093
P2860
P356
P1476
Interferon-alpha treatment of ...... ociated with the Yaa mutation.
@en
P2093
Anne Davidson
Meera Ramanujam
Michael P Madaio
Philip Kahn
Stephen M Factor
Weiqing Huang
P2860
P304
P356
10.1002/ART.24414
P577
2009-04-01T00:00:00Z